Efficacy and safety of repeat treatment courses of rituximab (RTX) in RA patients (pts) with inadequate response (IR) to tumor necrosis factor (TNF) inhibitors: long-term experience from REFLEX study
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.